Regentis Biomaterials Ltd (RGNT) Stock Price, Quote & News

Company Profile

Regentis Biomaterials Ltd., a regenerative medicine company, develops and commercializes tissue repair solutions in the United States. It offers Gelrin, a platform based on hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen for the treatment and regeneration of damaged or diseased tissue; and GelrinC, a cell-free and off-the-shelf hydrogel, which is in Phase II clinical trial for the treatment of cartilage injuries in the knee. The company was incorporated in 2004 and is...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 972 9 960 1917

Website: www.regentis.co.il

Address:

60, Medinat Hayehudim, Entrance C Herzlia Pituach, Herzliya, Israel

LaMaChery May. 11 at 9:59 AM

$RGNT bio ticker with s1 open

0 · Reply

TA_Kongen May. 4 at 2:11 PM

$RGNT S-1 active. So very thin. Prob see some kind of move before effect and offering. Thinkequity is the player.

0 · Reply

MotionOffense78 May. 1 at 10:04 PM

$RGNT load this drop.

1 · Reply

sydneyinsydney Apr. 27 at 8:44 PM

$RGNT this will pump eventually. gonna bet $100. high roller

0 · Reply

itrekntravel Apr. 1 at 5:23 PM

$RGNT Don't know about its prospects, but i do know i had to let go of my shares. No movement, no news = stagnant when i could trade/invest those funds elsewhere. Serious GL to all! ☘️

0 · Reply

choyler97 Mar. 11 at 5:49 PM

$RGNT Is this company and stock even alive anymore????

0 · Reply

Victory777777 Mar. 5 at 3:53 PM

$RGNT is the next $BNAI

0 · Reply

sneeds_feed_N_seed Feb. 27 at 6:45 PM

$RGNT I think here is good to scale in, $6-8 again soon.(?)

0 · Reply

Victory777777 Feb. 23 at 1:24 PM

$NYT $RGNT

0 · Reply

Victory777777 Feb. 19 at 3:14 PM

$RGNT what happened to the stock?

0 · Reply

Regentis Biomaterials enters collaboration with Humanitas Research Hospital

Apr 16, 2026, 8:30 AM EDT - 27 days ago

Regentis Implements Strategy for Commercial Deployment of GelrinC(R) in Europe Through Collaboration with Humanitas Hospital and Leading Cartilage Repair Expert Prof. Elizaveta Kon

2026-03-17T13:07:43.000Z - 2 months ago

Regentis Biomaterials develops and patents solvent-free manufacturing process

Mar 17, 2026, 8:30 AM EDT - 2 months ago

Regentis Biomaterials Develops and Patents New Solvent-Free Manufacturing Process That Increases GelrinC Production Yield by 400%

2026-03-02T11:39:51.000Z - 2 months ago

Regentis Biomaterials initiated with a Buy at ThinkEquity

Feb 24, 2026, 4:15 PM EST - 2 months ago

Regentis Biomaterials Reports 2025 Financial Results and Provides Business Update

2026-02-19T13:57:38.000Z - 2 months ago

Regentis Biomaterials appoints Galit Reke as CMO

Feb 19, 2026, 8:30 AM EST - 2 months ago

Regentis Biomaterials Appoints Dr. Galit Reske as Chief Medical Officer: Brings Strong Track Record of Success in Cartilage Repair

2026-02-17T13:45:16.000Z - 3 months ago

Regentis Biomaterials expands European clinical site network

2026-02-04T14:01:34.000Z - 3 months ago

Regentis Biomaterials appoints Ori Gon as CFO, CBO

Feb 4, 2026, 8:33 AM EST - 3 months ago

Regentis Biomaterials Appoints Ori Gon as Chief Financial Officer and Chief Business Officer as GelrinC Progresses Towards Commercial Launch in Europe and Advances in U.S. Phase III FDA Trial

2026-01-29T13:50:51.000Z - 3 months ago

Regentis Biomaterials expanding Phase III GelrinC clinical site network

Jan 29, 2026, 8:33 AM EST - 3 months ago

Regentis Expanding Pivotal Phase III GelrinC Clinical Site Network: Adding Several Leading Orthopedic Centers Across the U.S.

2026-01-28T16:25:13.000Z - 3 months ago

Regentis Biomaterials Ltd trading resumes

2026-01-28T16:05:14.000Z - 3 months ago

Regentis Biomaterials Ltd trading halted, volatility trading pause

2026-01-20T14:00:22.000Z - 4 months ago

Regentis Biomaterials announces long-term imaging data on GelrinC

Jan 20, 2026, 8:33 AM EST - 4 months ago

Regentis' GelrinC Demonstrates Breakthrough in Regenerating Native-Like Cartilage Structure in Knee Repair on MRI Results Confirmed Using a Validated, Regulator-Accepted Method

2026-01-16T16:05:30.000Z - 4 months ago

Regentis Biomaterials Ltd trading resumes

2026-01-16T16:00:15.000Z - 4 months ago

Regentis Biomaterials Ltd trading halted, volatility trading pause

2026-01-06T14:00:16.000Z - 4 months ago

Regentis Biomaterials announces publication of GelrinC follow-up results

Jan 6, 2026, 8:21 AM EST - 4 months ago

Regentis' GelrinC Establishes Long-Term Durability of Cartilage Repair Through Quantitative MOCART Evaluation

2025-12-18T13:50:22.000Z - 5 months ago

Regentis Biomaterials granted U.S. patent for GelrinC

Dec 18, 2025, 8:35 AM EST - 5 months ago

Regentis Biomaterials Granted New U.S. Patent for its Off-the-Shelf Regenerative Cartilage Repair Product GelrinC

2025-12-08T15:30:10.000Z - 5 months ago

Opening Day: Regentis Biomaterials raises $10M in IPO

HYNE OTH PARK POAS SMJF

2025-12-08T13:55:06.000Z - 5 months ago

Regentis Biomaterials commences trading on NYSE

Dec 5, 2025, 4:10 PM EST - 5 months ago

Regentis Biomaterials Ltd. Announces Closing of Initial Public Offering

Dec 3, 2025, 7:23 PM EST - 5 months ago

Regentis Biomaterials Ltd. Announces Pricing of Initial Public Offering

Mar 11, 2025, 9:16 AM EDT - 1 year ago

Israeli hydrogel implant developer Regentis Biomaterials files and sets terms for a $10 million US IPO

Mar 11, 2025, 6:09 AM EDT - 1 year ago

Regentis Biomaterials IPO Registration Document (F-1)

LaMaChery May. 11 at 9:59 AM

$RGNT bio ticker with s1 open

0 · Reply

TA_Kongen May. 4 at 2:11 PM

$RGNT S-1 active. So very thin. Prob see some kind of move before effect and offering. Thinkequity is the player.

0 · Reply

MotionOffense78 May. 1 at 10:04 PM

$RGNT load this drop.

1 · Reply

sydneyinsydney Apr. 27 at 8:44 PM

$RGNT this will pump eventually. gonna bet $100. high roller

0 · Reply

itrekntravel Apr. 1 at 5:23 PM

$RGNT Don't know about its prospects, but i do know i had to let go of my shares. No movement, no news = stagnant when i could trade/invest those funds elsewhere. Serious GL to all! ☘️

0 · Reply

choyler97 Mar. 11 at 5:49 PM

$RGNT Is this company and stock even alive anymore????

0 · Reply

Victory777777 Mar. 5 at 3:53 PM

$RGNT is the next $BNAI

0 · Reply

sneeds_feed_N_seed Feb. 27 at 6:45 PM

$RGNT I think here is good to scale in, $6-8 again soon.(?)

0 · Reply

Victory777777 Feb. 23 at 1:24 PM

$NYT $RGNT

0 · Reply

Victory777777 Feb. 19 at 3:14 PM

$RGNT what happened to the stock?

0 · Reply

choyler97 Feb. 17 at 9:30 PM

$RGNT So much for taking a chance.

0 · Reply

Ahirman Feb. 17 at 7:42 PM

$RGNT looking for a re-entry wondering if > 3 is a start. We are already 1/2 the offering price

0 · Reply

PortfolioQuintessence Feb. 17 at 1:16 PM

$RGNT Obscure micro-cap; minimal information.

0 · Reply

Ahirman Feb. 10 at 9:36 PM

$RGNT a shame the CFO hire and promoting in Europe pharma market didn't at least stop the decline to trade sideways. Just constant down at the moment. Going to cut losses here and come back at 2-3 range. Maybe everyone is expecting the next move is a share offering

0 · Reply

choyler97 Feb. 10 at 5:22 PM

$RGNT This has been a disappointment......

1 · Reply

Guitars7 Feb. 9 at 6:06 PM

$RGNT What was the reason for sharp drop early February?

0 · Reply

ZenithYield Feb. 9 at 3:17 PM

$RGNT Regenerative medicine or biotech; field is promising but commercially unproven.

0 · Reply

Victory777777 Feb. 5 at 8:14 PM

$KELYB $RGNT

0 · Reply

Market Cap	11.27M
Revenue (ttm)	0.00
Net Income (ttm)	-13.65M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.25

Volume	4,854
Avg Vol	6,704
Day's Range	N/A - N/A
Shares Out	5.18M
Stochastic %K	14%
Beta	N/A
Analysts	Strong Sell
Price Target	$10.00